Onyx Files Carfilzomib For Accelerated Approval With Two Phase III Trials Ongoing
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA has expressed preference for having multiple confirmatory trials in the works to support an accelerated approval application.